Skip to main content
Clinical Trials/CTRI/2017/11/010382
CTRI/2017/11/010382
Completed
Phase 4

Comparison of different doses of midazolam to prevent etomidate induced myoclonus â?? a randomized, double-blind, placebo-controlled trial

niversity College of Medical Sciences and GTB Hospital0 sites164 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: null- Surgery under general anaesthesia
Sponsor
niversity College of Medical Sciences and GTB Hospital
Enrollment
164
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
September 7, 2018
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
niversity College of Medical Sciences and GTB Hospital

Eligibility Criteria

Inclusion Criteria

  • ASA I/II patients, of either sex, undergoing elective surgical procedures under general anaesthesia

Exclusion Criteria

  • Neuropsychological or neuromuscular disease,
  • Adrenal cortical dysfunction,
  • History of allergy to midazolam,
  • Those having received any analgesic or sedative within previous 24 hours
  • Pregnant or lactating women

Outcomes

Primary Outcomes

Not specified

Similar Trials